Back

Cardioverter-defibrillators in hypertrophic cardiomyopathy: a French multicenter study

28 August 2017 (15:03 - 15:12)
Organised by:
Congress Presentation Part of: Risk prediction for sudden cardiac death and ICD treatments Automatic implantable cardioverter / defibrillator ESC Premium Access ESC Congress 2017

About the speaker

Photo
Mr Pierre-Cyril Flechon

Hospital Brabois of Nancy, Vandoeuvre-Les-Nancy (France)

9 More presentations in this session

Presentation thumbnail
Targeted next-generation sequencing as a comprehensive test for patients with hypertrophic cardiomyopathy
Doctor R. Brugada Terradellas (Salt, ES)
Abstract Slides Video
Presentation thumbnail
Impact of the timing of coronary angiography in patients with resuscitated out of hospital cardiac arrest on survival
Professor F. Beygui (Caen, FR)
Abstract Slides Video
Presentation thumbnail
Periodic Repolarization Dynamics as risk predictor in patients with Long-QT Syndrome
Doctor K. Rizas (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Periodic Repolarization Dynamics as risk predictor after myocardial infarction: PRD-MI study
Doctor K. Rizas (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Opening a new front in the fight against sudden cardiac death: is it time for near-term prevention?
Doctor N. Karam (Beirut, LB)
Abstract Slides Video

Access the full session

Session thumbnail
Risk prediction for sudden cardiac death and ICD treatments

The Event

Event poster

ESC Congress 2017

28 August 2017 15:03 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources